PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Enolase inhibition alters metabolic hormones and inflammatory factors to promote neuroprotection in spinal cord injury.

Rat / Spinal cord injury

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 32650031 ↗2020Reported benefit

Enolase inhibition alters metabolic hormones and inflammatory factors to promote neuroprotection in spinal cord injury.

RatSpinal cord injuryContusionSprague-DawleyMalen = n = 3-8 per group (immunohistochemistry n = 3-6)Intravenous (tail vein)100 microg/kg in 100 microLFirst dose 15 min after injury

Model: T10 contusion spinal cord injury by the Perot weight-drop method, 5 g weight dropped from 8 cm onto a 0.3 cm impounder after T10 laminectomy under ketamine 80 mg/kg plus xylazine 10 mg/kg anaesthesia

Prolonged ENOblock administration attenuated injury-induced increases in vimentin, Cox-2 and caspase-1 at the lesion and reduced microglial and astrocytic activation. Neuroprotection was evident as recovery of neurofilament protein, increased NeuN and MBP, and reduced chondroitin sulfate proteoglyc…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.